Insurers and health care funds takenlegalactionagainst over its marketing work with Purdue Pharma.
ByDEE-ANN DURBIN AP company author
December 30, 2023, 12: 26 PM
FILE – OxyContin tablets are organized for a picture, Feb. 19, 2013, at a drugstore in Montpelier, Vt. In an arrangement exposed late Friday, Dec. 29, 2023, consulting company McKinsey and Co. has concurred to pay $78 million to settle declares from insuranceproviders and health care funds that its marketing work with Purdue Pharma, the maker of OxyContin, assisted fuel an opioid dependency crisis. (AP Photo/Toby Talbot, File)
The Associated Press
Consulting company McKinsey and Co. has concurred to pay $78 million to settle declares from insurancecompanies and health care funds that its work with drug business assisted fuel an opioid dependency crisis.
The arrangement was exposed late Friday in files submitted in federal court in San Francisco. The settlement should still be authorized by a judge.
Under the contract, McKinsey would develop a fund to compensate insuranceproviders, personal advantage strategies and others for some or all of their prescription opioid expenses.
The insuranceproviders argued that McKinsey worked with Purdue Pharma – the maker of OxyContin – to develop and use aggressive marketing and sales methods to gottenridof physicians’ bookings about the extremely addicting drugs. Insurers stated that required them to pay for prescription opioids rather than moresecure, non-addictive and lower-cost drugs, consistingof overthecounter pa